跳至主要内容
临床试验/NCT00756977
NCT00756977已完成3 期

BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

Braintree Laboratories12 个研究点 分布在 1 个国家目标入组 394 人开始时间: 2008年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
394
试验地点
12
主要终点
Efficacy - Preparation Quality Using a 4 Point Scale

研究概览

简要总结

This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female outpatients who are undergoing colonoscopy for a routinely accepted indication, including:
  • Evaluation of barium enema results
  • GI bleeding
  • Anemia of unknown etiology
  • Neoplastic disease surveillance
  • Abnormal Endosonography
  • Inflammatory bowel disease
  • Unknown diarrhea or constipation etiology
  • Polypectomy
  • Laser therapy
  • Routine screening
  • At least 18 years of age.
  • Otherwise in good health, as determined by physical exam and medical history.
  • If female, and of child-bearing potential, is using an acceptable form of birth control (hormonal birth control, IUD, double-barrier method, depot contraceptive, abstinent, or vasectomized spouse).
  • Negative urine pregnancy test at screening, if applicable.
  • In the Investigator's judgment, subject is mentally competent to provide informed consent to participate in the study.

排除标准

  • Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis, or megacolon.
  • Subjects with impaired consciousness that predisposes them to pulmonary aspiration.
  • Subjects who are undergoing colonoscopy for foreign body removal or decompression.
  • Subjects with clinically significant electrolyte abnormalities based on Visit 1 laboratory results.
  • Subjects who had previous significant gastrointestinal surgeries (e.g. colostomy, colectomy, gastric bypass).
  • Subjects who are pregnant or lactating, or intending to become pregnant during the study.
  • Subjects of childbearing potential who refuse a pregnancy test.
  • Subjects who are allergic to any preparation components
  • Subjects who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures.
  • Subjects who have participated in an investigational surgical, drug, or device study within the past 30 days.

研究组 & 干预措施

1

Experimental

multi-dose preparation for oral administration prior to colonoscopy

干预措施: BLI850 (Drug)

2

Active Comparator

multi-dose preparation for oral administration prior to colonoscopy

干预措施: polyethylene glycol 3350 based bowel preparation (Drug)

结局指标

主要结局

Efficacy - Preparation Quality Using a 4 Point Scale

时间窗: 2-day

Percentage of patients with a successful preparation (cleaning rated as "Good" or "Excellent"

次要结局

  • Serum Chemistry Results (mg/dL)(2 days)
  • Hematology Results (%)(2 days)
  • Serum Chemistry Results (U/L)(2 days)
  • Serum Chemistry Results (mEq/L)(2 days)
  • Serum Chemistry Results (g/dL)(2 days)
  • Serum Chemistry Results (GFR)(2 days)
  • Hematology Results (1000/MCL)(2 days)
  • Hematology Results - Hemoglobin(2 days)
  • Hematology Results - Red Blood Cells(2 days)
  • Serum Chemistry Results (Osmolality)(2 days)

研究者

发起方
Braintree Laboratories
申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验

BLI850 vs an Active Control Bowel Preparation in... | 临床试验